This site is intended for healthcare professionals only
LoginRegister
State-Wide Immunization Drive in Haryana Targets High-Risk AreasMelanoma vaccine could be available by 2025: Moderna CEO
State-Wide Immunization Drive in Haryana Targets High-Risk AreasJapan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at...
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USAAstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15
Complications from flu largely preventable with annual flu vaccineComplications from flu largely preventable with annual flu vaccine
Maternal COVID-19 Vaccination Lowers risk of infection by omicron varient among infants: JAMAMaternal COVID-19 Vaccination Lowers risk of infection by omicron varient among infants: JAMA
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck 21-valent Pneumococcal Conjugate Vaccine demonstrates superior immunogenicity for 10 of 11...
novavax to sell facility in BohumilNovavax updated COVID vaccine gets Emergency Use Listing from WHO
Updated adult immunization schedule for ages 19 years or older released by CDCUpdated adult immunization schedule for ages 19 years or older released by CDC
State-Wide Immunization Drive in Haryana Targets High-Risk AreasThe BMJ study examines long-term effectiveness of live shingles vaccine
Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for XenpozymeSanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli
First Chikungunya Vaccine gets FDA nodFirst Chikungunya Vaccine gets FDA nod
X